Canadian marijuana group Sundial Growers (NASDAQ:SNDL) has recently been in the limelight. SNDL stock, which started 2021 around 50 cents, saw a 52-week high of $3.96 on Feb. 11. Let’s delve into the weeds and take a closer look at the company. Source: Shutterstock Currently, shares are hovering around $1.60. By comparison, the ETFMG Alternative Harvest ETF (NYSEARCA:MJ),
Stocks to sell
With investors excited about U.S. federal pot legalization, major cannabis equities remain elevated. That includes Aphria (NASDAQ:APHA) stock. But, while the Canada-based cannabis company offers exposure to possible changes in U.S. marijuana law, it may not be the best way to wager on it. Source: Shutterstock Blame it on its pending merger with Tilray (NASDAQ:TLRY).
Let’s establish the fact that I am not a hater of Starbucks (NASDAQ:SBUX) stock. In fact, I was a fan when it mattered most. When the going got tough last year, I saw past the pandemic problems. I supported SBUX stock with my article March 17. Source: Natee Meepian / Shutterstock.com That was one day
As the most dominant online advertising player in the world, Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) calls the shots. When Google says the rules of the game change, they change. The company’s recent move to end its behavioral targeting policies have been welcome news for privacy advocates. In the eyes of many consumers, this move was a long time
Over the last six weeks — as interest rates have risen and the economy has moved closer to normalcy — there has been a great deal of concern on Wall Street about overvalued stocks. In many ways, despite the correction of growth stocks, I’m more upbeat on those equities as a whole than other pundits.
As cryptocurrencies soar, investors are turning toward mining plays like SOS Limited (NYSE:SOS) stock. It’s a questionable, and even dangerous, strategy. Source: Mark Agnor / Shutterstock.com That’s not because cryptocurrencies are due for a collapse. I don’t believe that at all. In fact, I believe the opposite. I’m a long-time crypto bull. In theory, the
Since the its initial public offering (IPO) in late September, the shares of Palantir Technologies (NYSE:PLTR) have logged impressive gains, up about 190%. This has put the market capitalization at $48.7 billion. Although, as has been the case with other hot tech operators lately, PLTR stock has come under pressure. The price has gone from
Marijuana stocks have cooled off in recent weeks. Organigram Holdings (NASDAQ:OGI) stock was once a “can’t lose” bet, but it has turned out to be a volatile one with plenty of risk. Source: Shutterstock Let’s examine the company-specific and sector-specific concerns driving this volatility. Lack of U.S. Presence Is a Real Issue for OGI Stock
Perhaps one of my most glaring criticisms from an editing standpoint is that I write long introductory paragraphs. So, for those who have suffered from my loquaciousness, here’s perhaps my shortest lede ever. It may be time to rethink Nio (NYSE:NIO), and therefore to sell NIO stock. Before I get into it, let’s discuss some
Car stocks, especially shares of electric vehicles (EVs), have turbocharged portfolios in the past year. Meanwhile, the auto industry — which increasingly relies on semiconductors — has been in the limelight. However, due to the current chip shortage, many car makers have announced they would be temporarily halting production. As a result, car stocks have
Organigram Holdings (NASDAQ:OGI) is just another one of the many Canadian cannabis companies struggling to get profitable. As a result, OGI stock is down 26% from its high of $6 on Feb. 10. Good luck with this company getting profitable enough to justify that price again. Source: Shutterstock In fact, in the past year OGI
ChargePoint Holdings (NYSE:CHPT), an EV charging company that has come to market via the Switchback Energy Acquisition Corp. (NYSE:SBE) SPAC, has been a volatile. Indeed, CHPT stock has fallen approximately 40% from its 52-week high late last year. Source: Michael Vi / Shutterstock.com There are a couple of factors driving shares lower. Among these are the rise
iBio (NYSEAMERICAN:IBIO) stock is up 12% in the past year and up 74% in the year-to-date period. However, since I last wrote about IBIO stock on Nov. 20, the stock is mostly flat, including two big drops,lending credence to my concerns. Source: Shutterstock My worry at the time was that the company would continue to issue
Walmart (NYSE:WMT) knows how to wow the markets. It told the world and analysts during its February 18 earnings release that it expects “low single digits” in sales growth. Meaning 1% or 2%. As a result, don’t expect WMT stock to take off this year like a thunderbolt. Source: Ken Wolter / Shutterstock.com Moreover, Walmart’s
In hindsight, CRISPR Therapeutics (NASDAQ:CRSP) represented a once-in-a-blue-moon opportunity during the March doldrums of last year. For a brief moment, CRSP stock slipped below $40 as the world turned its eyes on the rapidly escalating novel coronavirus pandemic. However, shares didn’t stay deflated for long as they continued to march steadily higher despite the surrounding
Everybody loves a great deal. The problem for shopping mall operator Tanger Factory Outlet Centers (NYSE:SKT) is that increasingly, consumers have shifted their purchases online. This dynamic was in play well before the novel coronavirus struck, as you can see from the declining trend of SKT stock over the last five years. Source: Ritu Manoj
Sundial Growers (NASDAQ:SNDL) stock is another of the equities that got caught up in the Reddit wars. Source: Shutterstock Fundamentally it shows some real weakness, and I’ve yet to see any really well-thought out arguments that would convince me to consider buying it. Yet, the hype that surrounds it does represent a real opportunity for
From the perspective of investing on narratives, Clovis Oncology (NASDAQ:CLVS) seems to represent an ideal contrarian investment, perhaps even one of the better ones given its “cheap” price tag. After all, that’s what moves markets these days, isn’t it? Seriously, though, sentiment should rise for CLVS stock as novel coronavirus cases decline, yet it seems
Technically, undergarment maker Naked Brand Group (NASDAQ:NAKD) is one of the best performers of the year so far. Since January’s opening session, NAKD stock has delivered both longtime shareholders and recent speculators nearly 300%. Source: Shutterstock That’s a bonkers figure, one that takes away some of the pain associated with this investment, depending on when